Philip Wagenheim sold $1.3M of Immunome (IMNM)

Executed Mar 20, disclosed Mar 23, 3 days later.

Value, as filed

$1.3M

65,000 sh across 2 lots

Executed

Mar 20

the trade date, as filed

Disclosed

Mar 23

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Philip Wagenheim Director profile →

Philip Wagenheim (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Immunome, Inc. (IMNM). The largest single filing was $1.3M of IMNM (65,000 sh across 2 lots, as filed), executed Mar 20.

The name

IMNM

Immunome, Inc. IMNM · Healthcare · 26 filings in 24 months ticker →

Healthcare · Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-dr…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→